	US 12,187,686 B2
	BRD4-JAK2 inhibitors
Ernst Schönbrunn, Tampa, FL (US); Nicholas J. Lawrence, Tampa, FL (US); Harshani R. Lawrence, Tampa, FL (US); and Gary Reuther, Tampa, FL (US)
Assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, FL (US)
Appl. No. 17/274,287
Filed by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, FL (US)
PCT Filed Sep. 9, 2019, PCT No. PCT/US2019/050147 § 371(c)(1), (2) Date Mar. 8, 2021, PCT Pub. No. WO2020/051571, PCT Pub. Date Mar. 12, 2020.
Claims priority of provisional application 62/728,465, filed on Sep. 7, 2018.
Claims priority of provisional application 62/728,457, filed on Sep. 7, 2018.
Prior Publication US 2021/0355088 A1, Nov. 18, 2021
Int. Cl. C07D 239/47 (2006.01); C07D 401/12 (2006.01)

CPC C07D 239/47 (2013.01) [C07D 401/12 (2013.01)]

8 Claims

1. A compound selected from:

or a salt thereof.